Sign in
PF272 GLASDEGIB WITH LDAC IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNSUITABLE FOR INTENSIVE CHEMOTHERAPY: EFFECTS ON TRANSFUSIONS AND MARROW RECOVERY VS LDAC ALONE
Journal article   Open access  Peer reviewed

PF272 GLASDEGIB WITH LDAC IN NEWLY DIAGNOSED PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) UNSUITABLE FOR INTENSIVE CHEMOTHERAPY: EFFECTS ON TRANSFUSIONS AND MARROW RECOVERY VS LDAC ALONE

E.S. Wang, M. Heuser, P. Montesinos, M.A. Sekeres, A. Merchant, C. Pedro Olive, O. Salamero, J.K. McCloskey, C.J. Hoang, W.D. Ma, …
HemaSphere, Vol.3(S1), p.87
2019-06
url
https://doi.org/10.1097/01.hs9.0000559300.20719.08View
Published (Version of record) Open

Metrics

2 Record Views

Details